KUPANDO
Developer of a biotechnology platform designed to stimulate innate immunity to address unmet needs in cancer and infectious diseases. The company offers dual TLR agonist therapies with innate immune-t...
Valuation
$0
Share Price
N/A
Total Raised
$12.9M
Last Round
N/A